Deletions within the Epstein-Barr Virus Latent Membrane Protein-1 Oncogene in Adult Ordinary, HIV-Associated and Paediatric Hodgkin's Disease

References

• Chapman A LN, Rickinson A B. Epstein-Barr virus in Hodgkin's disease. Ann Oncol 1998; 9: S5–S16
   PubMed Web of Science ®Google Scholar
• Jarrett R F, Gallagher A, Jones D B, Alexander F E, Krajewski A S, Kelsey A, Adams J, Angus B, Gledhill S, Wright D H, Cartwright R A, Onions D E. Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age. J Clin Pathol 1991; 44: 844–848
   PubMed Web of Science ®Google Scholar
• Jarrett A F, Armstrong A A, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996; 7: S5–S10
   PubMed Web of Science ®Google Scholar
• Audouin J, Diebold J, Pallensen G. Frequent expression of Epstein-Barr virus latent membrane protein in tumour cells of Hodgkin's disease in HIV-positive patients. J Pathol 1992; 167: 381–384
   PubMed Web of Science ®Google Scholar
• Deacon E M, Pallesen G, Niedobitek G, Brooks L, Rickinson A B, Young L S. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med 1993; 177: 339–349
   PubMed Web of Science ®Google Scholar
• Baichwal V R, Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 1988; 2: 461–467
   PubMed Web of Science ®Google Scholar
• Kaye K M, Izumi K M, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993; 90: 9150–9154
   PubMed Web of Science ®Google Scholar
• Huen D S, Henderson S A, Croom-Carter D, Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 1995; 10: 549–560
   PubMed Web of Science ®Google Scholar
• Kieff E. Epstein-Barr virus: Increasing evidence of a link to carcinoma. N Engl J Med 1995; 333: 724–726
   PubMed Web of Science ®Google Scholar
• Devergne O, Hatzivassiliou E, Izumi K M, Kaye K M, Kleijnen M F, Kieff E, Mosialos G. Association of TRAF-1, TRAF-2, and TRAF-3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kB activation. Mol Cell Biol 1996; 16: 7098–7108
   PubMed Web of Science ®Google Scholar
• Izumi K M, Kieff E D. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kB. Proc Natl Acad Sci USA 1997; 94: 12592–12597
   PubMed Web of Science ®Google Scholar
• Gratama J W, Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 1995; 67: 197–255
   PubMed Web of Science ®Google Scholar
• Hu L -F, Chen F, Zheng X, Ernberg I, Cao S -L, Christensson B, Klein G, Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP-1. Oncogene 1993; 8: 1575–1583
   PubMed Web of Science ®Google Scholar
• Hu L -F, Zabarovsky E R, Chen F, Cao S -L, Ernberg I, Klein G, Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72: 2399–2409
   PubMed Web of Science ®Google Scholar
• Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt B F, Delsol G, Pallesen G. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937–2942
   PubMed Web of Science ®Google Scholar
• Sandvej K, Peh S -C, Andresen B S, Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 84: 4053–4060
   PubMed Web of Science ®Google Scholar
• Santón A, Manzanal A I, Campo E, Bellas C. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol: Mol Pathol 1995; 48: M184–M187
   Web of Science ®Google Scholar
• Bellas C, Santón A, Manzanal A, Campo E, Martín C, Acevedo A, Varona C, Forteza J, Morente M, Montalbán C. Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection. Am J Surg Pathol 1996; 20: 1520–1524
   PubMed Web of Science ®Google Scholar
• Pelstring R J, Zellmer R B, Sulak L E, Baks P M, Clare N. Hodgkin's disease in association with human immunodeficiency virus infection: pathologic and immunologic features. 1991; 67: 1865–1873
   Google Scholar
• Ree H J, Strauchen J A, Khan A A, Gold J E, Crowley J P, Kahn H, Zalusky R. Human immunodeficiency virus-associated Hodgkin's disease: clinico-pathologic study of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 1991; 67: 1614–1621
   PubMed Web of Science ®Google Scholar
• Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. Cancer 1994; 73: 2400–2407
   PubMed Web of Science ®Google Scholar
• Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, Franceschi S, Boiocchi M, Carbone A. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the italian cooperative group on AIDS and tumors. J Clin Oncol 1995; 13: 1758–1767
   PubMed Web of Science ®Google Scholar
• Andrieu J M, Roithmann S, Tourani J M, Levy R, Desablens B, Ie Maignan C, Gastant J A, Brice P, Raphael M, Taillan B. Hodgkin's disease during HIV1 infection: The french registry experience. Ann Oncol 1993; 4: 635–641
   PubMed Web of Science ®Google Scholar
• Reynolds P, Saunders L D, Layefsky M E, Lemp G F. The spectrum of adcquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980–1987. Am J Epidemiol 1993; 137: 19–30
   PubMed Web of Science ®Google Scholar
• Kaplan H S. Hodgkin's disease2^nd edn. Harvard University Press, Cambridge 1980
   Google Scholar
• Ambinder R F, Browning P J, Lorenzana I, Leventhal B G, Cosenza H, Mann R B, MacMahon E ME, Medina R, Cardona V, Grufferman S, Olshan A, Levin A, Petersen E A, Blattner W, Levine P H. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462–467
   PubMed Web of Science ®Google Scholar
• Chang K L, Albújar P F, Chen Y -Y, Johnson R M, Weiss L M. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496–501
   PubMed Web of Science ®Google Scholar
• Preciado M V, De Matteo E, Díez B, Menárguez J, Grinstein S. Presence of Epstein-Barr virus and strain type assigment in Argentine childhood Hodgkin's disease. Blood 1995; 86: 3922–3929
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P JR, Niggli F, Green E K, Nyong'o A O, Othieno-Abinya N A, Riyat M S, Raafat F, Mann J R. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood 1996; 87: 3828–3836
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P JR, Niggli F, Powell J E, Raafat F, Hesseling P B, Schneider J W, Hartley P S, Tzortzatou-Stathopoulou F, Khalek E RA, Mangoud A, EI-Safy U R, Madanat F, Al Sheyyab M, Mpofu C, Revesz T, Rafii R, Tiedemann K, Waters K D, Barrantes J C, Nyongo A, Riyat M S, Mann J R. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996; 74: 27–31
   PubMed Web of Science ®Google Scholar
• Sculley T B, Apolloni A, Hurren L, Moss D J, Cooper D A. Coinfection with A-and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 1990; 162: 643–648
   PubMed Web of Science ®Google Scholar
• Borisch B, Finke J, Hennig I, Delacrétaz F, Schneider J, Heitz P HU, Laissue J A. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 1992; 168: 229–236
   PubMed Web of Science ®Google Scholar
• Boyle M J, Vasak E, Tschuchnigg M, Turner J J, Sculley T, Penny R, Cooper D A, Tindall B, Sewell W A. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood 1993; 81: 468–474
   PubMed Web of Science ®Google Scholar
• De Re V, Boiocchi M, De Vita S, Dolcetti R, Gloghini A, Uccini S, Baroni C, Scarpa A, Cattoretti G, Carbone A. Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. Int J Cancer 1993; 54: 895–898
   PubMed Web of Science ®Google Scholar
• Donaldson S S. Hodgkin's disease in children. Sem Oncol 1990; 17: 736–748
   PubMed Web of Science ®Google Scholar
• Slivnick D J, Ellis T M, Nawrocki J F, Fisher R I. The impact of Hodgkin's disease on the immune system. Sem Oncol 1990; 17: 673–682
   PubMed Web of Science ®Google Scholar
• Dolcetti R, Zancai P, de Re V, Gloghini A, Bigoni B, Pivetta B, De Vita S, Carbone A, Boiocchi M. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the italian poulation and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 1997; 89: 1723–1731
   PubMed Web of Science ®Google Scholar
• Mori S, Itoh T, Tokunaga M, Eizuru Y. Deletions and single-base mutations within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of southern Japan. J Med Virol 1999; 57: 152–158
   PubMed Web of Science ®Google Scholar
• Chen W -G, Chen Y -Y, Bacchi M M, Bacchi C E, Alvarenga M, Weiss L M. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996; 148: 17–23
   PubMed Web of Science ®Google Scholar
• Miller W E, Edwards R H, Walling D M, Raab-Traub N. Sequence variation in the Epstein-Barr virus latent membrane protein I. J Gen Virol 1994; 75: 2729–2740
   PubMed Web of Science ®Google Scholar
• Kingma D W, Weiss W B, Jaffe E S, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Sixbey J W, Shirley P, Chesney P J, Buntin D M, Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2: 761–765
   PubMed Web of Science ®Google Scholar
• Yao Q Y, Tierney R J, Croom-Carter D, Dukers D, Cooper G M, Ellis C J, Rowe M, Rickinson A B. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocom-promised individuals. J Virol 1996; 70: 4884–4894
   PubMed Web of Science ®Google Scholar
• Kieff E, Liebowitz D. Epstein-Barr virus and its replication. Virology2^nd edn, B N Fields, D M Knipe. Raven Press, New York 1990; 1889–1920
   Google Scholar
• Weiss L M, Movahed L A, Warnke R A, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Gulley M L, Eagan P A, Quintanilla-Martínez L, Picado A L, Smir B N, Childs C, Dunn C D, Craig F E, Williams J W, Banks P M. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: Association with mixed cellularity subtype and hispanic american ethnicity. Blood 1994; 83: 1595–1602
   PubMed Web of Science ®Google Scholar
• Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 1995; 333: 901–906
   PubMed Web of Science ®Google Scholar
• Chan W C, Delabie J. Single cell analysis of H/RS cells. Ann Oncol 1996; 7: S41–S43
   PubMed Web of Science ®Google Scholar
• Roth J, Daus H, Gause A, Trümper L, Pfreundschuh M. Detection Of Epstein-Barr virus DNA in Hodgkin-and Reed-Stemberg-cells by single cell PCR. Leukemia and Lymphoma 1994; 13: 137–142
   PubMed Web of Science ®Google Scholar